In hepatocellular carcinoma patients, the best chosen cut off of serum IFITM3 was 835.5 ng/l yield AUC = 0.79, with a sensitivity 98% and a specificity 60% as shown in Table 4. This evidence concerns the gene IFITM3 and hepatocellular carcinoma.